VDYNE, INC.

Profile

Company Names

VDYNE, INC.
VDYNE LLC

Addresses

10900 73RD AVENUE NORTH, SUITE 116, MAPLE GROVE, MN 55369

10990 73RD AVENUE NORTH, SUITE 116, MAPLE GROVE, MN 55369

10990 73RD AVENUE, SUITE 116, MAPLE GROVE, MN 55369

Phone Numbers

763-777-5969

 

Entity Type:

CORPORATION

Industry:

BIOTECHNOLOGY

Year Incorporated:

2017

State Incorporated:

DELAWARE

Total Amount Raised:

$33,004,237.00

Number of Funding Rounds:

4
Investment Rounds
Round #
Round Open Date
Amount Raised
Total Round Size
Amount Remaining to be Raised
Securities
4
2020-12-09 
$8,000,001.00 
$8,000,001.00 
$0.00 
Equity 
3
2020-08-14 
$13,000,062.00 
$13,000,062.00 
$0.00 
Equity 
2
2019-12-18 
$6,799,999.00 
$6,800,000.00 
$1.00 
Equity 
1
2017-08-01 
$5,204,175.00 
$5,204,175.00 
$0.00 
Equity 
People
First Name
Middle Name
Last Name
Titles
Related Companies
JEAN-RAYMOND 
 
BOULLE II 
DIRECTOR
VDYNE LLC   |  VDYNE, INC.
LUCIAN 
 
LOZONSCHI 
DIRECTOR
VDYNE LLC   |  VDYNE, INC.
EDWARD 
W 
MALOUF 
EXECUTIVE OFFICER, PROMOTER
VDYNE LLC
DAVID 
 
MCINTYRE 
DIRECTOR, EXECUTIVE OFFICER
HEARTWARE INTERNATIONAL, INC.   |  TENDYNE HOLDINGS, INC.   |  QDP TOPCO LLC   |  ADVANCED ENT SOLUTIONS INC   |  VYTRONUS INC   |  TUSKER MEDICAL, INC.   |  GALA THERAPEUTICS, INC.   |  VDYNE LLC   |  VDYNE, INC.
GREG 
 
PEARL 
DIRECTOR
TENDYNE HOLDINGS, INC.   |  VDYNE LLC   |  VDYNE, INC.
ROBERT 
 
VIDLUND 
EXECUTIVE OFFICER, DIRECTOR
VDYNE LLC   |  VDYNE, INC.
Filings
Filing Date
Filing Type
Source URL
Industry Classifier
Detailed Industry
Revenue Range
Securities
First Sale Date
2020-12-18
D
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2020-12-09 
2020-08-31
D
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2020-08-14 
2020-01-02
D
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2019-12-18 
2018-12-11
D
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2017-08-01 
Brokers
Broker Dealer
Broker CRD#
Recipient Name
Recipient CRD#